SCHEMBL357603

SCHEMBL357603

Cc1cccc(C)c1CO

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 2/20 0.48
GABRG2 P18507 1/20 0.48
GABRB3 P28472 1/20 0.48
ALDH1A1 P00352 4/20 0.48
CYP2A6 P11509 2/20 0.43
CYP1A2 P05177 1/20 0.43
TSHR P16473 2/20 0.42
ACHE P22303 1/20 0.42
ATM Q13315 3/20 0.42
TRPA1 O75762 2/20 0.42
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CA9 Q16790 1/20 0.41
TAAR1 Q96RJ0 2/20 0.38
PDCD1 Q15116 1/20 0.37
CD274 Q9NZQ7 1/20 0.37
HTR1D P28221 1/20 0.36
CD44 P16070 1/20 0.36
GABRB2 P47870 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2009339 0.85 CD44 (0.52) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL148754 0.85 PDCD1 (0.45) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL31606366 0.85 CD44 (0.52) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL3077796 0.85 TRPA1 (0.52) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL606472 0.83 ALDH1A1 (0.48) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL2087457 0.83 ACHE (0.48) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL20962808 0.83 GABRA1 (0.40) GABRA1GABRG2GABRB3ALDH1A1CYP2A6
SCHEMBL1007985 0.83 AKR1B1 (0.43) GABRA1GABRG2GABRB3ALDH1A1TAAR1
SCHEMBL3414808 0.81 GABRA1 (0.40) GABRA1GABRG2GABRB3ALDH1A1CYP1A2
SCHEMBL30366318 0.81 GABRA1 (0.40) GABRA1GABRG2GABRB3ALDH1A1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 935 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12559582-B2 Polyacrylate polymer BASF SE (DE) 2026-02-24 US claimed
CN-114394922-B Preparation method of N-substituted pyrrolyl aryl propenone compound 河南农业大学 2024-06-11 CN claimed
CN-117964834-A Polyacrylate polymers 巴斯夫欧洲公司 2024-05-03 CN claimed
CN-117431551-A Inhibitor-free cleaning agent and method for cleaning conductive member for organic electroluminescent display device using the same 丰元化学有限公司 2024-01-23 CN claimed
CN-116555080-A Preparation method of hybrid ester compound containing oxazole ring 上海交通大学医学院附属仁济医院 2023-08-08 CN claimed
CN-114394922-A Preparation method of N-substituted pyrrolyl aryl propenone compound 河南农业大学 2022-04-26 CN claimed
CN-114213307-A Preparation method of N-alkyl substituted pyrrolidone compound 河南农业大学 2022-03-22 CN claimed
EP-3898730-A1 POLYACRYLATE POLYMER BASF SE (DE) 2021-10-27 EP claimed
CN-113195564-A Polyacrylate polymers 巴斯夫欧洲公司 2021-07-30 CN claimed
WO-2020127463-A1 POLYACRYLATE POLYMER BASF SE (DE) 2020-06-25 WO claimed
CN-106608776-A Synthetic method of imine 中国科学院大连化学物理研究所 2017-05-03 CN claimed
CN-102388014-A Synthesis method of chiral alpha-aryl propionic acid derivative DSM IP ASSETS BV 2012-03-21 CN claimed
US-20120029226-A1 METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2012-02-02 US claimed
EP-2393771-A1 Method for the synthesis of chiral alpha-aryl propionic acid derivatives DSM IP Assets B.V. (NL) 2011-12-14 EP claimed
WO-2010089343-A1 METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES DSM IP ASSETS B.V. (NL) 2010-08-12 WO claimed
US-6620823-B2 Antiinflammatory agents; rheumatic disorders BRISTOL-MYERS SQUIBB PHARME COMPANY 2003-09-16 US claimed
US-12559582-B2 Polyacrylate polymer BASF SE (DE) 2026-02-24 US disclosed
CN-120117960-A Impurity compound and preparation method thereof 天津全和诚科技有限责任公司 2025-06-10 CN disclosed
US-3947472-A ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC SYNTEX CORPORATION (PM) 1976-03-30 US disclosed
US-3935273-A ANTIINFLAMMATORY, ANALGESIC, ANTIPYRETIC, ANTIPRURITIC SYNTEX CORPORATION (US) 1976-01-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12559582-B2 Polyacrylate polymer SAAL1, ATXN2L, VCL GABRA1 2346/4885GABRG2 2975/4885GABRB3 2949/4885
US-20120029226-A1 METHOD FOR THE SYNTHESIS OF CHIRAL ALPHA-ARYL PROPIONIC ACID DERIVATIVES GRIA1, GRIA3, GRIA2 GABRA1 12/4885GABRG2 54/4885GABRB3 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.